Vera Therapeutics Income After Taxes 2020-2024 | VERA

Vera Therapeutics income after taxes from 2020 to 2024. Income after taxes can be defined as earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.

Vera Therapeutics Income After Taxes 2020-2024 | VERA

Vera Therapeutics income after taxes from 2020 to 2024. Income after taxes can be defined as earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.
Related Stocks
Company NameMarket
Cap
Amgen (AMGN)$178.9B
Regeneron Pharmaceuticals (REGN)$125.5B
Vertex Pharmaceuticals (VRTX)$122.4B
Gilead Sciences (GILD)$104.4B
Bristol Myers Squibb (BMY)$100.8B
CSL (CSLLY)$96.8B
GSK (GSK)$87.9B
Alnylam Pharmaceuticals (ALNY)$35.1B
Argenex SE (ARGX)$31.6B
Biogen (BIIB)$28.8B
BioNTech SE (BNTX)$27.5B
Moderna (MRNA)$26.9B
Illumina (ILMN)$20.9B
BeiGene (BGNE)$19.2B
Genmab (GMAB)$17.3B
BioMarin Pharmaceutical (BMRN)$13.5B
Vaxcyte (PCVX)$13B
Exact Sciences (EXAS)$12.8B
Incyte (INCY)$12.6B
Insmed (INSM)$12.5B
Bio-Techne Corp (TECH)$12.1B
Sarepta Therapeutics (SRPT)$11.9B
QIAGEN (QGEN)$10.4B
Bio-Rad Laboratories (BIO.B)$9.1B
Legend Biotech (LEGN)$9.1B
Roivant Sciences (ROIV)$8.9B
Ascendis Pharma (ASND)$8.7B
Repligen (RGEN)$8B
Halozyme Therapeutics (HALO)$7.9B
Intra-Cellular Therapies (ITCI)$7.9B